R-Hyper-CVAD Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cyclophosphamide, vincristine, doxorubicin and dexamethasone, administered on a hyperfractionated schedule, plus rituximab that may be used to treat HIV-related B-cell lymphoma, Burkitt lymphoma, chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma, and acute lymphoblastic leukemia (ALL).

**Synonyms:** - Hyper-CVAD Plus Rituximab - HyperCVAD-Rituximab - HyperCVAD/Rituximab - R-HCVAD - R-Hyper-CVAD - R-HyperCVAD - Rituximab Plus HyperCVAD - Rituximab and Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone Regimen - Rituximab-HyperCVAD